Comments

Ocular Therapeutix Stock Price, Quotes and Forecasts

Q: What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

OCULNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.14

At close: May 29 EDT

$8.14

0.000.00%

Pre-Market: 4:00 PM EDT

Ocular Therapeutix (OCUL) Forecast

News Earnings Ocular Therapeutix (OCUL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Ocular Therapeutix Stock Price, Quotes and Forecasts | NASDAQ:OCUL | Benzinga

Explore Ocular Therapeutix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCUL.

Open	-
Close	-
Volume / Avg.	0 / 1.77M
Day Range	- - -
52 Wk Range	4.79 - 11.78
Market Cap	$1.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	8.72%
Days to Cover	7.67

Recent News

Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings

Ocular Therapeutix shares are trading lower by 13.3% Monday afternoon. The company reported worse-than-expected Q1 financial results.

Henry Khederian

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside

Needham starts coverage on Ocular Therapeutix with a Buy rating, citing Axpaxli's potential in wet AMD and forecasting $1.5 billion peak sales.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.77M
Day Range	- - -
52 Wk Range	4.79 - 11.78
Market Cap	$1.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	8.72%
Days to Cover	7.67

About Ocular Therapeutix Inc

Sector

Health Care

Industry

Pharmaceuticals

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and con...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ocular Therapeutix (OCUL) stock?

You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.

View our list of the best stock brokerages

Who are Ocular Therapeutix (OCUL) competitors?

Other companies in Ocular Therapeutix’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for Ocular Therapeutix (OCUL) stock?

Ocular Therapeutix has a consensus price target of $16.33.

What is the current price for Ocular Therapeutix (OCUL)?

The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $8.14 last updated May 29, 2025 at 4:00 PM EDT.

Does Ocular Therapeutix (OCUL) pay a dividend?

There are no upcoming dividends for Ocular Therapeutix.

When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?

Ocular Therapeutix’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Ocular Therapeutix (OCUL) going to split?

There is no upcoming split for Ocular Therapeutix.

What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.